Infection with mouse hepatitis virus (MHV) strain A59 produces and Cavanagh, 1997). Infections with nidoviruses, including acute hepatitis, encephalitis, and chronic demyelination in mice. Howboth coronaviruses and arteriviruses, have been used as ever, little is known about a closely related strain, MHV-2, which is experimental model systems for a variety of neurologic disonly weakly neurotropic. To better understand the molecular basis of neurotropism of MHVs, we compared the pathogenesis and genomic eases . MHV infection of mice is a useful sequence of MHV-2 with that of MHV-A59. Intracerebral injection of laboratory model system for virus-induced demyelination MHV-2 into 4-week-old C57B1/6 mice produces acute meningitis and that mimics many of the pathologic features of multiple hepatitis without encephalitis or chronic inflammatory demyelination.
Involvement of the central nervous system (CNS) in MHV-
has been reported for MHV-2 (Yokomori et al., 1991; Yamada et al., 1997) . Thus, in the present study we character-A59 infection includes meningitis (infection of the meninized the pathogenesis and sequence analysis of MHV-2 and ges, the covering layers surrounding the brain and spinal compared it with the previously reported pathogenesis and cord), myelitis (infection of the spinal cord), and encephalitis sequence analysis of MHV-A59 (Armstrong et al., 1983 , (infection of the brain). The distribution of the acute lesions 1984; Budzilowicz et al., 1985; Budzilowicz and Weiss, in the brain exhibits a predilection for anatomic locations 1987; Luytjes et al., 1988; Bredenbeek et al., 1990 ; Zoltick involving the olfactory and limbic systems and several conet al., 1990; Bonilla et al., 1994) . nections of these areas with the basal ganglia and brainstem centers (Lavi et al., , 1990 . Spread of MHV within the brain is facilitated by interneuronal transport (Barthold, 1988; Barnett et al., 1993; Sun and Perl-MATERIALS AND METHODS man, 1995) . This mode of transport of MHV can be best demonstrated when virus is introduced directly into the nose where there is direct contact between virus and nerve endings
Viruses and Cells of the susceptible olfactory neurons (Barthold, 1988; Barnett et al., 1993) . In other viral infections, Plaque-purified viruses MHV-A59 (Lavi et al., 1984a,b ; such as poliomyelitis virus, a combination of interneuronal Budzilowicz et al., 1985) and MHV-2 (Keck et al., 1988 ) transport and hematogenous spread has also been demonwere used throughout this study. Viruses were propagated strated (Mims, 1982) .
and assayed in L2 murine fibroblast cells at 37ЊC in DMEM MHV-induced CNS infection is associated with viral per-(Gibco) containing 10% heat-inactivated fetal bovine serum sistence, often manifested as low levels of viral RNA without (FBS) and 1% penicillin/streptomycin in the presence of 5% detectable viral titers (Lavi et al., 1984a; Das Sarma et al., CO 2 . The ability of viruses to induce cell-to-cell fusion was 2000). Immunologic sequelae of MHV infection of the brain determined by the proportion of cells involved in syncytia include enhanced expression of MHC class I RNA and antiformation. Infection of the viruses in L2 cells (moi ϭ 1 PFU/ gens (Suzumura et al., 1986 (Suzumura et al., , 1988 Lavi et al., 1987a,b, cell) was examined to assess viral growth in tissue culture. 1989; Gombold and Weiss, 1992 ) and a state of activation
The preparation of primary glial cell cultures was performed as previously described (Suzumura et al., 1986 ; Lavi of proinflammatory and chemoattractant cytokines (Pearce et al., 1987a,b) . Briefly, brains were removed aseptically et Lane et al., 1998) . Viral persistence may be from 1-day-old B6 mice, passed through 19-and then 23-facilitated by the development of mutant viruses escaping gauge needles, and seeded in culture for 3 days at 37ЊC in recognition by cytotoxic T lymphocytes to avoid viral clear-DMEM (Gibco) containing 20% heat-inactivated FBS and ance (Pewe et al., 1998) . Studies of immunologically defi-1% penicillin/streptomycin in the presence of 5% CO 2 . After cient and immunosuppressed mice suggest that MHV-incells adhered to the dish or flask, the percentage of FBS duced demyelination is an immune-mediated phenomenon was reduced to 10%. Cultures were characterized by immu- (Wang et al., 1990; Houtman and Fleming, 1996a,b) and nofluorescence using glial fibrillary acidic protein (GFAP) may be in part T-cell-dependent (Fleming et al., 1993) . Howantibodies as a marker for astrocytes. These mixed glial ever, the relationship among neurotropism, viral persistence, cultures were consistently over 90% GFAP-positive at the MHC induction, autoimmunity, and demyelination is still untime of infection. Cultures were infected at approximately clear.
10-14 days postextraction by incubation with virus (moi ϭ To better understand the molecular basis of neurotropism 1) for 1 h and then the unattached viral particles were reassociated with MHV infection, we selected an MHV to moved by washing the cultures three times with PBS. study that does not invade the brain and does not produce demyelination. Comparative genomic sequence analysis between viruses with different phenotypes, along with targeted Virulence of Viruses in Mice recombination between these viruses, is then used to elucidate molecular determinants of neurotropism. As a weakly
The virulence of each one of the MHVs in mice was neurotropic strain of MHV we chose MHV-2, which is determined by the dose that killed 50% of the mice (LD 50 ). closely related to MHV-A59, and little is known about the Groups of 4-week-old C57Bl/6 (B6) (The Jackson Laborapathogenesis of this strain (Hirano et al., 1974 (Hirano et al., , 1981 ; Wege tories, Bar Harbor, ME) mice were infected intracerebrally with 10-fold serial dilutions of the viruses. Five to 10 mice et al., 1981). Moreover, only minimal sequence information were injected IC with each viral dilution. Mice were moniimmunostaining kit (Biomeda Corp., Foster City, CA), which utilizes avidin-biotin complex with alkaline phosphatored daily for 14 days for signs of disease and death. The LD 50 was calculated according to the Reed-Muench formula tase as the marker enzyme, was used in all experiments (Guesdon et al., 1979) . The kit utilizes Fast Red/naphthol (Reed and Muench, 1938 3, 5, 7, 9, 11, 13 , and 30 days RNA extracted from virus-infected L2 cells (moi ϭ 1), and postinoculation, 2-4 mice per time point were sacrificed by harvested 16 h post infection. Complementary DNA was methoxyflurane or CO 2 overdose. Mice were perfused with synthesized using oligonucleotide primers based on pre-10 ml PBS and then 10 ml 10% buffered formalin (Sigma, viously published MHV-A59 sequences (Leparc-Goffart et St. Louis, MO). Organs including thymus, liver, brain, and al., 1997). Primers were designed to amplify fragments of spinal cord were removed and fixed in formalin for an addiapproximately 600 base pairs. PCR products were purified tional 48 h. Tissues were embedded in paraffin, sectioned with QIAquick PCR purification kit (Qiagen, Chatsworth, at 5 M, and stained with hematoxylin and eosin (H&E). CA) and sequenced by automated sequencing using the Taq Brain and spinal cord sections were also stained with Luxol dye terminator procedure according to the manufacturer's Fast Blue for myelin. Each brain was serially sectioned into protocol (Taq DyeDeoxy Terminators cycle sequencing kit, five to seven coronal sections. Five to seven cross sections Applied Biosystems, Foster City, CA). The primers used for of spinal cords were prepared, representing cervical, thosequencing were the same ones that were used for amplificaracic, and lumbar regions of the cord. To better demonstrate tion. Each fragment was sequenced in both directions. Seprimary demyelination (loss of myelin sheaths surrounding quence analysis was performed using the computer program intact neuronal axons), some mice were perfused with 2% Sequencher, version 3.0. We compared the nucleotide seglutaraldehyde (Sigma), and spinal cord sections were emquences and predicted protein sequences to the sequences bedded in Epon and stained with toluidine blue (Lavi et al., available at the NCBI GenBank using the "Blast n and Blast 1984b). For assessment of viral titers, brains and livers were p" search and the FASTA program. We carried out homology aseptically removed from mice following PBS perfusion and plots using the computer program MacVector, version 6.0, kept frozen at Ϫ80ЊC. Tissue samples were homogenized and the ClustalW program for multiple alignments among and tested for viral titers by plaque assays in six-well plates the various sequences. The sequencing data was submitted (Lavi et al., 1984b; Gombold et al., 1993) .
to GenBank (Accession Number AF201929).
Immunohistochemistry RESULTS Formalin-fixed paraffin-embedded tissue samples were deparaffinized, rehydrated through graded alcohols, and permeabilized in 0.2% Triton X-100/PBS for 15 min. Tissue
Infection of Tissue Culture Cells and Mice with MHV-2 was then incubated with the primary antibody (polyclonal and MHV-A59 rabbit anti-MHV, 1:100 dilution) at 37ЊC for 1 h and isotypematched negative controls were used at similar concentraInfections with both MHV-A59 and MHV-2 reached titers of approximately 2 ϫ 10 7 PFU/ml in 24 h in L2 cells. While tions. Tissue sections with each control antibody were used in each individual experiment. The UltraProbe universal MHV-A59 produced large plaques and syncytia formation in over 80% of the cultured L2 cells at the peak of lytic corresponded with hematogenous spread of virus to both organs at that stage. MHV-2 infection did not produce eninfection, MHV-2 produced small plaques and no syncytia except for occasional three nuclei in a cell in less than 2% cephalitis and after 5 days postinjection there were no detectable titers in the brains. However, a detectable amount of of the cells (similar to uninfected cultures).
We infected groups of mice IC with each virus and asvirus was still present at 7 days postinfection in the brains of mice infected with MHV-A59. sessed the kinetics of viral replication and the pathological changes induced by each virus (Fig. 1) . Viral titers in the We then analyzed the pathologic changes in mice infected with the two viruses. Following IC injection of 4-week-old liver of mice infected with MHV-A59 and MHV-2 appeared on day 3 and peaked on day 5 postinfection. Viral titers in B6 mice, 1000 PFU of MHV-A59 produced acute meningoencephalitis and hepatitis and, subsequently, chronic CNS the brain appeared in both viral infections on the first day postinfection, partially representing the residual viral inocudemyelinating disease as previously described (Lavi et al., 1984b (Lavi et al., , 1990 . Brain pathology following MHV-A59 lum. Titers then rose on day 3 to 10 3 -10 5 PFU/g in A59 infection and to 10 6 PFU/g in MHV-2 infection, representing infection consisted of focal acute encephalitis, characterized by inflammatory infiltrates of mononuclear cells, predomithe stage of meningitis in these infections. Then in A59 infection titers of virus peaked at 10 7 -10 8 PFU/g, whereas nantly lymphocytes, microglial proliferation, microglial nodules, and neuronophagia. Areas of involvement included the titers of MHV-2 in infected brains declined on day 5 and were 2 log 10 less than MHV-A59. The difference the regions of the brain typically susceptible to MHV-A59 infection (Lavi et al., , 1990 . Liver pathology of moderbetween the titers of the two viruses on day 5 was consistent with the presence of encephalitis in A59 infection that ate hepatitis following MHV-A59 infection was characterized by multiple foci of necrosis throughout the liver. Each peaked in parallel to the spread of virus to the liver and area of necrosis consisted of hepatocytes, cellular and nuclear debris, and polymorphonuclear and lymphocytic inflammatory infiltrates. Infection (IC) of 4-week-old B6 mice with 1000 PFU of MHV-2 produced severe hepatitis. The time course of hepatitis following MHV-2 infection was similar to that seen following MHV-A59 infection. However, the hepatic lesions following MHV-2 infection were more extensive and in many cases the individual foci of necrosis and inflammation in the liver coalesced into confluent liver damage. In the brain, MHV-2 caused meningitis without encephalitis (Figs.  2 and 3) . Focal mononuclear inflammatory cells were found in the meninges and choroid plexus and minimal, if any, invasion of the brain parenchyma. Since the LD50 of the two viruses was different we also compared the pathogenesis of the two viruses given both at one LD 50 dose. The results were similar to those described above.
To further analyze the difference in viral spread between MHV-2 and MHV-A59, we studied the distribution of viral antigens in brain sections. Imunohistochemical analysis of brain sections at various days postinfection (1,3,5,7) revealed mild viral antigen detection in the meninges (Fig. 4) , choroids plexus, and ependymal cells at 3 and 5 days postinfection, without staining of brain parenchyma for MHV antigen. We concluded that there was minimal, if any, invasion of MHV-2 into brain parenchyma. This could result from either a lack of ability of the virus to infect parenchymal brain To rule out the inability of MHV-2 to infect brain cells we studied the interaction between the viruses with primary in MHV-A59 infected mice, but no demyelination was seen in mice infected with MHV-2 (Fig. 5) . mixed glial culture prepared from B6 mouse brains. Infection of the cultures with both MHV-2 and MHV-A59 produced similar titers of approximately 10 7 PFU/ml after 48 h postinSequence Comparison between MHV-2 and MHV-A59 fection. These results indicated that lack of invasion of the Genomes brain was probably not due to inability of MHV-2 to infect brain cells (at least those of glial origin).
We sequenced the entire 31-kb genome of MHV-2 and Multiple sections of spinal cord from mice infected with compared it with the known MHV-A59 sequences. Consenthe two viruses were examined for myelin loss and inflamsus sequencing was carried out by RT-PCR of viral mRNA matory lesions at 30 days postinoculation. MHV-A59 caused amplified from infected cells . chronic spinal cord demyelination that was detected in all of
The leader sequence of MHV-2 had 10 nucleotide substituthe mice by H&E-, LFB-, or toluidine-blue-stained sections.
tions and 1 nucleotide insertion compared to the leader seHowever, mice infected with MHV-2 did not exhibit chronic quence of MHV-A59. 25-nucleotide overlap. The ORF 1a sequence of MHV-2 (Pachuk et al., 1989) , were conserved, including two hydrophobic regions, a membrane-anchoring domain, a picorshowed 94% of sequence identity and 97% of similarity with MHV-A59. There was a 53-aa deletion in the 5Ј end navirus 3C-like protease domain, two papain-like protease domains, and a conserved domain known as X, of yet un-RNA of ORF 1a in MHV-2 (aa 987-1040), and a 1-aa deletion in position 2091 of 1a in comparison to MHVknown function. ORF1b of the two viruses had 98% identity and 99% similarity. A59. The functional domains of ORF 1a, as defined in A59 Sequence analysis of the S gene of MHV-2 revealed 83% relative to MHV-A59. The S2 subunit of MHV-2 had additional deletions of 2 adjacent aa and 1 isolated aa. identity and 92% similarity with MHV-A59 and was identical to the published sequence of the MHV-2 S gene (Yamada ORF 2b, encoding a hemagglutinin-esterase (HE) protein, is expressed only in very few strains of MHV. ORF2b of et al., 1997). The hypervariable region in the S1 domain of MHV-2 contained a 43-aa insertion and a 3-aa deletion, MHV-A59 lacks a translational initiation codon, thus making it a pseudogene. The HE gene of MHV-2 contained mutaThe M gene sequences of MHV-2 shared sequence identity of 95% and sequence similarity of 99% with that of MHVtions, deletions, and insertions. The ORF 2b of MHV-2 stopped prematurely after 97 aa compared to the 413 aa of A59. Within the coding region of 684 nucleotides there were 44 nucleotide changes, which resulted in 10 aa substitutions the ORF 2b of MHV-A59.
ORF 5b of MHV-2 encoded the E protein of 88 aa. The in a protein of 228 residues (S2T, E9Q, V20I, Q21R, I37V, I52V, I59L, V96I, I97M, A221M). In aa position 2 of MHVORF5b product of MHV-A59 lacked the 5 carboxy-terminal aa relative to the predicted MHV-2 polypeptide. The MHV-A59 there is a serine, whereas MHV-2 had a threonine; both are potential O-glycosylation sites. A potential N-glycosyla-2 5b gene had overall sequence identity of 90% and sequence similarity of more than 93% compared to MHV-A59. MHVtion site in position 27 was present in both MHV-2 and MHV-A59. 2 had a 5-aa addition (IIQTL) at the carboxy terminal and 7-aa substitutions (F20V, V51L, Y57C, L58V, D60N, M73V,
The N gene of MHV-2 had 92% sequence identity and 95% sequence similarity with that of MHV-A59. Like other L75P) compared with MHV-A59. The MHV-A59 E protein encoded by the 5b gene contains no potential N-glycosylaknown sequences of MHV N proteins, the MHV-2 N gene was composed of three highly conserved structural domains tion sites. However, there was a potential N-glycosylation site in residue 60 of MHV-2. In addition, MHV-2 contained connected to each other by spacer sequences. Sequence divergences of 31 aa clustered in the two-spacer regions. There a potential protein kinase C phosphorylation site in residues 36-38 (SIK).
was a 4-aa deletion at the 5Ј end and a 1-aa addition at the 3' end of the N gene of MHV-2. The nonconserved residues (Das Sarma et al., 2000) , The unique phenotype of MHV-2 provides a new experimental model system of MHV-induced in spacer A of MHV-2 were more like JHM than MHV-A59 except for the last 2 aa, but spacer B of MHV-2 was unique meningitis without encephalitis and without CNS persistence and demyelination. Additional studies are currently under- (Parker et al., 1989) .
The sequence of gene 2 of MHV-2 revealed two open way to explore the interaction of MHV-2 with the BBB and the ability of MHV-2 to infect a variety of neuronal and reading frames similar to other MHVs. ORF2a potentially encoded a 265-aa polypeptide, compared to the 261-aa-long glial cells and to propagate within the CNS. Sequence analysis of MHV-2 was submitted in its entirety polypeptide of MHV-A59. It shared 90% sequence identity and 93% sequence similarity with MHV-A59. There was a to GenBank. Except for the HE protein, all four other structural protein genes of MHV-2 (S, E, M, and N) display a nucleotide substitution G to A after the intergenic sequence ORF1 /2 which caused the 4-aa early initiation of ORF 2a.
low level of sequence diversity. The MHV-2 replicase gene and the genes for structural proteins S, E, M, and N share There was a 4-aa insertion at the amino terminal end and 25-aa substitutions within the entire coding region of MHV-83-95% sequence identity with those of MHV-A59. However, the nonstructural genes, 2a, 4, and 5a, differ markedly 2 ORF 2a.
Gene 4 of MHV-2 was disrupted by several frame shifts, between MHV-A59 and MHV-2 in number and nucleotide sequence, due to deletions, insertions, and frame shift mutagenerating very short segments. There were two point mutations, one in the 4th aa in ORF4a and the other in ORF 4b, tions. These genes are nonessential for MHV replication (Luytjes et al., 1988; Schwarz et al., 1990; Yokomori et al. , which resulted in disruption of the open reading frames. The ORF5a of MHV-A59 consists of only 112 aa. Within the 1991; Fischer et al., 1997) , and therefore their effect on viral replication or pathogenesis is probably coding region of 107 aa of the MHV-2 ORF 5a, there were 12 aa substitutions and a 5-aa deletion at the amino terminal not significant. Coronaviruses contain the largest genome size among of MHV-2 compared to MHV-A59. RNA viruses. The task of engineering and transcribing an infectious RNA of MHV from a cDNA clone of the entire genome has not been achieved to date. Thus, mapping of DISCUSSION biologic properties to viral genes has been dependent on indirect and correlative studies. Studies using monoclonal antibodies to modify pathogenic properties, and phenotypesequence correlation of mutant and variant viruses, linked MHV-2 is a naturally isolated strain of MHV (Hirano et al., 1974 (Hirano et al., , 1981 Wege et al., 1981) . It is known to be mainly determinants of pathogenesis to the S, M, and HE proteins (Collins et al., 1982; Knobler et al., 1982; Buchmeier et al., hepatotropic;  however, detailed information about the neurotropic properties of MHV-2 has not been previously reported. 1984; Dalziel et al., 1986; Fleming et al., 1989; Lavi et al., 1990; Laude et al., 1992; Hingley et al., 1994 ; LeparcIn this first detailed analysis of the pathogenesis of MHV-2 we show that MHV-2 produces acute meningitis and severe . However, since incidental mutational events and natural recombination during coronavirus evoluhepatitis in 4-week-old B6 mice. Unlike MHV-A59, a closely related strain, MHV-2 has a limited ability to invade the tion may hinder studies of biologic properties of MHVs, it is important to provide phenotype-sequence correlation of brain and thus does not cause encephalitis. Reduced viral titers are recovered from the brains of infected mice, comadditional recombinants, mutants, and natural strains of MHV which share a specific biologic property (such as lack pared to MHV-A59, and the majority of viral replication appears to be in the meninges, choroid plexus, and ependyma of demyelination). This information can then be used for targeted recombination that has been recently adopted for without involvement of brain parenchyma. The inability of MHV-2 to cause encephalitis even when injected intracerepathogenesis studies of MHV (Lavi et al., 1998 a, b; LeparcGoffart et al., 1998; Phillips et al., 1999) . We have recently brally may not be due to lack of ability of the virus to infect brain cells since glial cells can be infected in vitro. Thus, produced new recombinant viruses containing the S gene of MHV-2 on an MHV-A59 background. These new recombi-MHV-2 may lack the ability to cross the BBB or to propagate within the CNS. nant viruses show that the S gene affects pathogenesis properties such as demyelination (Das Sarma et al., 2000) and MHV-2 also does not produce inflammatory autoimmune demyelination. Moreover, recent studies in our laboratory hepatitis (Navas et al., 2001 ).
In conclusion, we describe here, for the first time, a dedemonstrate that unlike MHV-A59, MHV-2 does not persist in the central nervous system as revealed by RT-PCR analysis tailed analysis of the pathogenesis and complete sequence Budzilowicz, C. J., Wilczynski, S. P., and Weiss, S. R. (1985) . Three analysis of MHV-2, a weakly neurotropic virus that causes 
